CSPN — Carespan Health Income Statement
0.000.00%
- CA$0.95m
- CA$2.98m
- $2.53m
Annual income statement for Carespan Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 5.76 | 4.54 | 2.53 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 12.1 | 7.68 | 4.56 |
Operating Profit | -6.3 | -3.14 | -2.03 |
Total Net Non Operating Interest Income / Expense | |||
Net Income Before Taxes | -6.86 | -3.14 | -2.03 |
Provision for Income Taxes | |||
Net Income After Taxes | -6.86 | -3.14 | -2.03 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | -6.53 | -2.89 | -2.03 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -6.53 | -2.89 | -2.03 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.652 | -0.11 | -0.044 |